Nautilus Biotechnology, Inc.
NAUT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$70,780 | -$63,675 | -$57,924 | -$50,315 |
| Dep. & Amort. | $6,353 | $5,705 | $3,416 | $2,842 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12,701 | $12,137 | $10,380 | $7,934 |
| Change in WC | -$5,459 | -$3,219 | -$788 | -$22 |
| Other Non-Cash | -$1,960 | -$2,659 | -$890 | $320 |
| Operating Cash Flow | -$59,145 | -$51,711 | -$45,806 | -$39,241 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,122 | -$2,442 | -$2,324 | -$2,269 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$86,278 | -$112,892 | -$186,591 | -$221,795 |
| Inv. Sales/Matur. | $0 | $71,599 | $163,175 | $85,100 |
| Other Inv. Act. | $154,650 | $0 | $0 | $0 |
| Investing Cash Flow | $66,250 | -$43,735 | -$25,740 | -$138,964 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,144 | $368 | $562 | -$7,962 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $335,409 |
| Financing Cash Flow | $1,144 | $368 | $562 | $327,447 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,249 | -$95,078 | -$70,984 | $149,242 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,399 | $115,477 | $186,461 | $37,219 |
| End Cash | $28,648 | $20,399 | $115,477 | $186,461 |
| Free Cash Flow | -$61,267 | -$54,153 | -$48,130 | -$41,510 |